Ethyl 2-(3-Chlorophenyl)sulfanylacetate, 25g

2-(3-Bromophenyl)-1H-indole, 95.0%, 1g

4-(3,5-Dimethyl-1H-pyrazol-4-yl)benzoic acid, 97%, 1g

2-Bromo-4-(cyclopentyloxy)-5-ethoxybenzaldehyde, 250mg

(4R,5R)-2-Methyl-α,α,α',α',2-pentaphenyl-1,3-dioxolane-4,5-dimethanol, 98%, 100mg

Fmoc-D-Cys(Trt)-OH, >95%, 500g

3-Morpholin-4-ylbenzonitrile, 97.0%, 25g

(S)-Ethyl 2-(((benzyloxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanoate, 95.0%, 100g

Methyl 6-hydroxy-1H-indole-2-carboxylate, 95.0%, 500mg

(5E)-2-mercapto-5-[4-(trifluoromethyl)benzylidene]-1,3-thiazol-4(5H)-one, 95.0%, 5g

5-(4-fluorophenyl)-1,2,4-thiadiazol-3-amine, 95.0%, 1g

monoclonale murino anti-GST-tag, F50-3D12.2, 25 µg

(5R)-1-(tert-butoxycarbonyl)-5-methyl-D-proline, 95.0%, 10g